Instruction for use: Calcium dobesilate tablets 250 mg

Dosage form: tablets

Active substance: Calcii dobesilas

ATX

C05BX01 Calcium dobezilate

Pharmacological group

Antiaggregants

Angioprotectors and microcirculatory correctors

The nosological classification (ICD-10)

I70.9 Generalized and unspecified atherosclerosis: Systemic atherosclerosis

I79.2 Peripheral angiopathy in diseases classified elsewhere: diabetic angiopathy; Angiopathy in diabetes; arteriosclerosis diabetic; Pain in lesions of peripheral nerves; Diabetic angiopathy; Diabetic microangiopathy; Diabetic vascular disease; Intermittent angioneurotic disbaziya; Macroangiopathy in diabetes; microangiopathy; Microangiopathy in diabetes mellitus; Tingling sensations in the hands and feet; Coldness in the extremities; Peripheral angiopathy; Peripheral arterial disease; Sclerosis Menkeberga; Chronic obliterating diseases of arteries

I80 Phlebitis and thrombophlebitis: Diseases of peripheral vessels; Inflammation of superficial veins; Inflammatory diseases of veins; Deep venous thrombophlebitis; The disease of veins; Disease of the veins of the lower extremities; Diseases of peripheral vessels; Migrating phlebitis; Insufficiency of veins of lower extremities; Exacerbation of chronic thrombophlebitis; Acute thrombophlebitis; Acute thrombophlebitis of superficial veins; Periphlebitis; Periflebit surface; Superficial inflammation of veins; Surface thrombophlebitis; Surface phlebitis; Thrombophlebitis; Deep vein thrombophlebitis; Thrombophlebitis superficial; Phlebitis; Phlebitis of deep veins; Phlebitis of superficial veins; Phlebopathy; Chronic thrombophlebitis; Endophlebitis

Composition and release form

1 tablet contains calcium dobesilate 250 mg; In the package 50 and 100 pcs.

Pharmacology

Mode of action - Antiaggregational, angioprotective.

Indications for Calcium dobesilate tablets 250 mg

Diabetic angiopathies, glomerulosclerosis, atherosclerosis of the vessels of the lower extremities, thrombophlebitis of superficial veins, hemodynamic disorders of arteriovenous origin.

Contraindications for Calcium dobesilate tablets 250 mg

No.

Pregnancy and breast-feeding

Possibly.

Side effects

Not identified.

Dosage and Administration

Inside, after eating - 1 tablet 3 times a day. Course - from 3 weeks (with phlebopathy) to 6-8 months.

Storage conditions of Calcium dobesilate tablets 250 mg

In a dry place protected from light.

Keep out of the reach of children.

Shelf life

2 years

Do not use beyond the expiration date printed on the package.